TFF PHARMACEUTICALS, INC. Additional Paid in Capital
TFF PHARMACEUTICALS, INC. had Additional Paid in Capital of $121.57 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2023-08-14
- 2023-06-30: Additional Paid in Capital $121.57M.
- 2023-03-31: Additional Paid in Capital $120.80M.
- 2022-12-31: Additional Paid in Capital $120.07M.
- 2022-09-30: Additional Paid in Capital $107.92M.
| Period end | Additional Paid in Capital |
|---|---|
| 2023-06-30 | $121.57M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $120.80M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $120.07M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $107.92M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $106.46M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $105.26M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $104.08M 10-K · filed 2023-03-31 |
| 2021-09-30 | $103.16M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $102.30M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $101.54M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $71.65M 10-K · filed 2022-03-24 |
| 2020-09-30 | $70.01M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $45.19M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $44.90M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $43.34M 10-K · filed 2021-03-10 |
| 2019-09-30 | $206.46K 10-Q · filed 2019-12-09 |
| 2018-12-31 | $596.72K 10-K · filed 2020-03-27 |